[HTML][HTML] Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults

YL Kasamon, J Bolaños-Meade, GT Prince… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
YL Kasamon, J Bolaños-Meade, GT Prince, HL Tsai, SR McCurdy, JA Kanakry, GL Rosner…
Journal of Clinical Oncology, 2015ncbi.nlm.nih.gov
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With
High-Dose Post-Transplantation Cyclophosphamide in Older Adults - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content
Main Navigation Search PMC Full-Text Archive Search in PMC Advanced Search User
Guide Journal List J Clin Oncol PMC4582145 Other Formats PubReader PDF (370K) Actions
Cite Collections Share Permalink Copy RESOURCES Similar articles Cited by other articles …
Abstract
Purpose
Recent advances in nonmyeloablative (NMA), related HLA-haploidentical blood or marrow transplantation (haplo-BMT) have expanded the donor pool. This study evaluated the effect of age on NMA haplo-BMT outcomes in patients age 50 to 75 years.
ncbi.nlm.nih.gov